Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

NOVARTIS

  • FDA Approval
  • Nov. 18, 2022, 12:40 UTC
  • 24
  • 0 comments

FDA approve ALPELISIB

Comment Full text

ELI LILLY AND CO

  • FDA Approval
  • Nov. 18, 2022, 12:40 UTC
  • 33
  • 0 comments

FDA approve DULAGLUTIDE

Comment Full text

CHEPLAPHARM

  • FDA Approval
  • Nov. 18, 2022, 12:40 UTC
  • 35
  • 0 comments

FDA approve ORLISTAT

Comment Full text

GLAND PHARMA LTD

  • FDA Approval
  • Nov. 18, 2022, 12:40 UTC
  • 34
  • 0 comments

FDA approve DESMOPRESSIN ACETATE

Comment Full text

DR REDDYS

  • FDA Approval
  • Nov. 18, 2022, 12:40 UTC
  • 37
  • 0 comments

FDA approve DIFLUPREDNATE

Comment Full text

LUPIN LTD

  • FDA Approval
  • Nov. 18, 2022, 12:40 UTC
  • 33
  • 0 comments

FDA approve RUFINAMIDE

Comment Full text

CONCORD BIOTECH LTD

  • FDA Approval
  • Nov. 18, 2022, 12:40 UTC
  • 33
  • 0 comments

FDA approve MYCOPHENOLATE MOFETIL

Comment Full text

CONCORD BIOTECH LTD

  • FDA Approval
  • Nov. 18, 2022, 12:40 UTC
  • 23
  • 0 comments

FDA approve MYCOPHENOLATE MOFETIL

Comment Full text

AMNEAL

  • FDA Approval
  • Nov. 18, 2022, 12:40 UTC
  • 24
  • 0 comments

FDA approve NEOSTIGMINE METHYLSULFATE

Comment Full text

SUN PHARM

  • FDA Approval
  • Nov. 18, 2022, 12:40 UTC
  • 26
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text
  • Previous
  • 936
  • 937
  • 938
  • 939
  • 940
  • Next

Search

News categories

  • Technical Exchange News(12316)
  • Event(6229)
  • SEC News(268158)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(156223)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin